These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 37552364)
1. Correction to: An Immunoinformatics-Based Study of Mycobacterium tuberculosis Region of Difference-2 Uncharacterized Protein (Rv1987) as a Potential Subunit Vaccine Candidate for Preliminary Ex Vivo Analysis. Arega AM; Dhal AK; Pattanaik KP; Nayak S; Mahapatra RK Appl Biochem Biotechnol; 2024 Apr; 196(4):2396. PubMed ID: 37552364 [No Abstract] [Full Text] [Related]
2. Mycobacterium tuberculosis Rv1987 induces Th2 immune responses and enhances Mycobacterium smegmatis survival in mice. Sha S; Shi X; Deng G; Chen L; Xin Y; Ma Y Microbiol Res; 2017 Apr; 197():74-80. PubMed ID: 28219528 [TBL] [Abstract][Full Text] [Related]
3. Mycobacterium tuberculosis Rv1987 protein induces M2 polarization of macrophages through activating the PI3K/Akt1/mTOR signaling pathway. Sha S; Shi Y; Tang Y; Jia L; Han X; Liu Y; Li X; Ma Y Immunol Cell Biol; 2021 Jul; 99(6):570-585. PubMed ID: 33469941 [TBL] [Abstract][Full Text] [Related]
4. Computational discovery and ex-vivo validation study of novel antigenic vaccine candidates against tuberculosis. Arega AM; Pattanaik KP; Nayak S; Mahapatra RK Acta Trop; 2021 May; 217():105870. PubMed ID: 33636152 [TBL] [Abstract][Full Text] [Related]
5. Liu Y; Zhang J; Leng G; Hu J; Wang W; Deng G; Ma Y; Sha S Front Cell Infect Microbiol; 2023; 13():1256866. PubMed ID: 38029253 [TBL] [Abstract][Full Text] [Related]
6. The role of immunoinformatics in the development of T-cell peptide-based vaccines against Ortega-Tirado D; Arvizu-Flores AA; Velazquez C; Garibay-Escobar A Expert Rev Vaccines; 2020 Sep; 19(9):831-841. PubMed ID: 32945209 [TBL] [Abstract][Full Text] [Related]
7. Secretory protein Rv1987, a 'probable chitinase' from Mycobacterium tuberculosis is a novel chitin and cellulose binding protein lacking enzymatic function. Prakash CM; Janakiraman V Biochem Biophys Res Commun; 2023 Dec; 684():149120. PubMed ID: 37879252 [TBL] [Abstract][Full Text] [Related]
8. Design of multi-epitope based vaccine against Nayak SS; Sethi G; Ramadas K J Biomol Struct Dyn; 2023; 41(23):14116-14134. PubMed ID: 36775659 [TBL] [Abstract][Full Text] [Related]
9. Mycobacterium tuberculosis Rv1090 and Rv1987 encode functional β-glucan-targeting proteins. Mba Medie F; Vincentelli R; Drancourt M; Henrissat B Protein Expr Purif; 2011 Feb; 75(2):172-6. PubMed ID: 20826214 [TBL] [Abstract][Full Text] [Related]
10. Designing of a Chimeric Vaccine Using EIS (Rv2416c) Protein Against Mycobacterium tuberculosis H37Rv: an Immunoinformatics Approach. Logesh R; Lavanya V; Jamal S; Ahmed N Appl Biochem Biotechnol; 2022 Jan; 194(1):187-214. PubMed ID: 34817805 [TBL] [Abstract][Full Text] [Related]
11. [A multi-stage and multi-epitope vaccine against Mycobacterium tuberculosis based on an immunoinformatics approach]. Ning Y; Cai Y; Liu X; Gu C; Meng X; Qiao J Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Jun; 39(6):494-500. PubMed ID: 37340917 [TBL] [Abstract][Full Text] [Related]
12. Development of multi-epitope based subunit vaccine against Kumari R S; Sethi G; Krishna R J Biomol Struct Dyn; 2024; 42(22):12365-12384. PubMed ID: 37880982 [TBL] [Abstract][Full Text] [Related]
13. Immunoinformatics analysis of antigenic epitopes and designing of a multi-epitope peptide vaccine from putative nitro-reductases of Mycobacterium tuberculosis DosR. Shiraz M; Lata S; Kumar P; Shankar UN; Akif M Infect Genet Evol; 2021 Oct; 94():105017. PubMed ID: 34332157 [TBL] [Abstract][Full Text] [Related]
14. Screening and evaluation of Mycobacterium tuberculosis diagnostic antigens. Ma Z; Ji X; Yang H; He J; Zhang Q; Wang Y; Wang Z; Chen C Eur J Clin Microbiol Infect Dis; 2020 Oct; 39(10):1959-1970. PubMed ID: 32548683 [TBL] [Abstract][Full Text] [Related]
15. Development of peptide vaccine candidate using highly antigenic PE-PGRS family proteins to stimulate the host immune response against Kumar A; Sharma P; Arun A; Meena LS J Biomol Struct Dyn; 2023 May; 41(8):3382-3404. PubMed ID: 35293852 [TBL] [Abstract][Full Text] [Related]
16. Insight Into Novel Anti-tuberculosis Vaccines by Using Immunoinformatics Approaches. Khan Z; Ualiyeva D; Amissah OB; Sapkota S; Hameed HMA; Zhang T Front Microbiol; 2022; 13():866873. PubMed ID: 35722321 [TBL] [Abstract][Full Text] [Related]
17. Reverse vaccinology approach to design a multi-epitope vaccine construct based on the Mycobacterium tuberculosis biomarker PE_PGRS17. Moodley A; Fatoba A; Okpeku M; Emmanuel Chiliza T; Blessing Cedric Simelane M; Pooe OJ Immunol Res; 2022 Aug; 70(4):501-517. PubMed ID: 35554858 [TBL] [Abstract][Full Text] [Related]
18. A multi-subunit based, thermodynamically stable model vaccine using combined immunoinformatics and protein structure based approach. Rana A; Akhter Y Immunobiology; 2016 Apr; 221(4):544-57. PubMed ID: 26707618 [TBL] [Abstract][Full Text] [Related]
19. Immunoinformatics Prediction and Protective Efficacy of Vaccine Candidate PiuA-PlyD4 Against Streptococcus Pneumoniae. Miao C; Cui Y; Li Y; Qi Q; Shang W; Chen H; Gao Y; Yuan R; Long Q; Wu W; Wang X; Yan Z; Jiang Y Drug Des Devel Ther; 2023; 17():3783-3801. PubMed ID: 38146490 [TBL] [Abstract][Full Text] [Related]
20. An immunoinformatics approach to design a multi-epitope vaccine against Mycobacterium tuberculosis exploiting secreted exosome proteins. Sharma R; Rajput VS; Jamal S; Grover A; Grover S Sci Rep; 2021 Jul; 11(1):13836. PubMed ID: 34226593 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]